ZA200610255B - Activable particles, preparations and uses - Google Patents
Activable particles, preparations and usesInfo
- Publication number
- ZA200610255B ZA200610255B ZA200610255A ZA200610255A ZA200610255B ZA 200610255 B ZA200610255 B ZA 200610255B ZA 200610255 A ZA200610255 A ZA 200610255A ZA 200610255 A ZA200610255 A ZA 200610255A ZA 200610255 B ZA200610255 B ZA 200610255B
- Authority
- ZA
- South Africa
- Prior art keywords
- particles
- relates
- activable
- preparations
- health
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title 1
- 239000011246 composite particle Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Paints Or Removers (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0405036A FR2869803B1 (fr) | 2004-05-10 | 2004-05-10 | Particules activables, preparation et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200610255B true ZA200610255B (en) | 2008-09-25 |
Family
ID=34945762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200610255A ZA200610255B (en) | 2004-05-10 | 2006-12-08 | Activable particles, preparations and uses |
Country Status (25)
Country | Link |
---|---|
US (2) | US9162079B2 (el) |
EP (1) | EP1744789B1 (el) |
JP (1) | JP5150251B2 (el) |
KR (2) | KR101234334B1 (el) |
CN (1) | CN100592921C (el) |
AT (1) | ATE403444T1 (el) |
AU (1) | AU2005251499B2 (el) |
BR (1) | BRPI0510290B8 (el) |
CA (1) | CA2564197C (el) |
CY (1) | CY1108369T1 (el) |
DE (1) | DE602005008731D1 (el) |
DK (1) | DK1744789T3 (el) |
EA (1) | EA010246B1 (el) |
ES (1) | ES2312004T3 (el) |
FR (1) | FR2869803B1 (el) |
HK (1) | HK1099508A1 (el) |
HR (1) | HRP20080534T3 (el) |
IL (1) | IL178877A (el) |
MX (1) | MXPA06013095A (el) |
PL (1) | PL1744789T3 (el) |
PT (1) | PT1744789E (el) |
RS (1) | RS50615B (el) |
SI (1) | SI1744789T1 (el) |
WO (1) | WO2005120590A1 (el) |
ZA (1) | ZA200610255B (el) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2867180B1 (fr) | 2004-03-02 | 2006-06-16 | Univ Claude Bernard Lyon | Nanoparticules hybrides comprenant un coeur de ln203 porteuses de ligands biologiques et leur procede de preparation |
FR2869803B1 (fr) | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | Particules activables, preparation et utilisations |
FR2877571B1 (fr) * | 2004-11-05 | 2007-04-13 | Nanobiotix Sarl | Nanoparticules pourvues d'un element de ciblage intracellulaire, preparation et utilisations |
CA2587392C (en) * | 2004-11-15 | 2013-02-12 | Australian Nuclear Science & Technology Organisation | Solid particles from controlled destabilisation of microemulsions |
US20070218049A1 (en) * | 2006-02-02 | 2007-09-20 | Wei Chen | Nanoparticle based photodynamic therapy and methods of making and using same |
EP2000150B1 (en) * | 2006-03-24 | 2016-07-13 | Toto Ltd. | Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle |
EP1852107A1 (en) * | 2006-04-19 | 2007-11-07 | Nanobiotix | Magnetic nanoparticles compositions and uses thereof |
EP1920784A1 (en) * | 2006-11-13 | 2008-05-14 | Koninklijke Philips Electronics N.V. | Radiation sensitizers in ionizing radiation therapy and imaging |
US9488916B2 (en) * | 2007-04-08 | 2016-11-08 | Immunolight, Llc. | Interior energy-activation of photo-reactive species inside a medium or body |
US9358292B2 (en) | 2007-04-08 | 2016-06-07 | Immunolight, Llc | Methods and systems for treating cell proliferation disorders |
FR2922106B1 (fr) * | 2007-10-16 | 2011-07-01 | Univ Claude Bernard Lyon | Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants. |
US8164074B2 (en) * | 2007-10-18 | 2012-04-24 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
GB2453860B (en) * | 2007-10-18 | 2011-03-16 | Searete Llc | Ionizing-radiation-responsive compositions,methods and systems |
US8227204B2 (en) * | 2007-10-18 | 2012-07-24 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8168958B2 (en) * | 2007-10-18 | 2012-05-01 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US9557635B2 (en) * | 2007-10-18 | 2017-01-31 | Gearbox, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8529426B2 (en) * | 2007-10-18 | 2013-09-10 | The Invention Science Fund I Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8684898B2 (en) * | 2007-10-18 | 2014-04-01 | The Invention Science Fund I Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US20090104113A1 (en) * | 2007-10-18 | 2009-04-23 | Searete Llc | Ionizing-radiation-responsive compositions, methods, and systems |
TWI574712B (zh) | 2008-02-21 | 2017-03-21 | 伊穆諾萊特公司 | 利用電漿子增強之光譜療法(pepst)及激子-電漿增強之光療法(epep)治療細胞增生病症之組合物及產生自體疫苗之系統 |
CL2009000560A1 (es) | 2008-03-11 | 2010-02-19 | Univ Duke | Un metodo para endurecer un medio endurecible por radiacion que comprende colocar una composicion dentro de un objeto para ser endurecido, la aplicacion de al menos uno elegido entre rayos x, rayos gama o haz de electrones a traves del objeto y dentro de la composicion. |
CN113274496A (zh) * | 2008-04-04 | 2021-08-20 | 免疫之光有限责任公司 | 用于原位光生物调节的非侵入性系统和方法 |
EP2130553A1 (en) | 2008-06-05 | 2009-12-09 | Nanobiotix | Inorganic nanoparticles of high density to destroy cells in-vivo |
WO2010009106A1 (en) * | 2008-07-14 | 2010-01-21 | Bourke Frederic A Jr | Advanced methods and systems for treating cell proliferation disorders |
BRPI0911715A2 (pt) | 2008-07-31 | 2019-09-24 | Alma Mater Studiorum - Universita' Di Bologna | partículas ativas para aplicações bio-analíticas e métodos para sua preparação. |
WO2010123993A1 (en) | 2009-04-21 | 2010-10-28 | Tuan Vo-Dinh | Non-invasive energy upconversion methods and systems for in-situ photobiomodulation |
TWI572389B (zh) * | 2009-11-10 | 2017-03-01 | 伊穆諾萊特公司 | 用於產生介質中之改變之儀器組及系統、用於產生光或固化之系統、輻射固化或可固化物品、微波或rf接受器及用於治療或診斷之系統 |
GB0921596D0 (en) | 2009-12-09 | 2010-01-27 | Isis Innovation | Particles for the treatment of cancer in combination with radiotherapy |
ES2880840T3 (es) | 2010-05-06 | 2021-11-25 | Immunolight Llc | Composición de unión adhesiva y método de uso |
HUE038539T2 (hu) | 2010-08-27 | 2018-10-29 | Sienna Biopharmaceuticals Inc | Készítmények eljárások célzott hõmodulációhoz |
US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
US9116246B2 (en) * | 2011-04-07 | 2015-08-25 | Stc.Unm | Thermal neutron detectors based on gadolinium-containing nanoscintillators |
WO2012153820A1 (ja) * | 2011-05-12 | 2012-11-15 | コニカミノルタエムジー株式会社 | X線吸収蛍光ナノ粒子 |
EP2729175B1 (en) | 2011-07-08 | 2021-12-01 | Duke University | System for light stimulation within a medium |
US9693957B2 (en) | 2011-07-08 | 2017-07-04 | The University Of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
WO2013035739A1 (ja) * | 2011-09-05 | 2013-03-14 | 株式会社Ihi | 温熱治療用材料、温熱治療用システム及び温熱治療方法 |
WO2013087920A1 (en) | 2011-12-16 | 2013-06-20 | Nanobiotix | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof |
MX2015004524A (es) | 2012-10-11 | 2015-09-25 | Nanocomposix Inc | Metodos y composiciones de nanoplacas de plata. |
SG11201510468TA (en) * | 2013-06-20 | 2016-01-28 | Nanobiotix | Compositions and methods for use in oncology |
MA38709A1 (fr) * | 2013-06-20 | 2018-05-31 | Nanobiotix | Compositions et procédés pour une utilisation en diagnostic médical |
FR3018451A1 (fr) | 2014-03-13 | 2015-09-18 | Chromalys | Nanoparticules pour leur utilisation dans la detection de tumeurs mobiles |
WO2015149188A1 (en) * | 2014-04-03 | 2015-10-08 | The Governing Council Of The University Of Toronto | Multifunctional nanoparticle compositions and uses thereof |
EP3206987B1 (en) | 2014-10-14 | 2020-07-01 | The University of Chicago | Nanoparticles for photodynamic therapy, x-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof |
US10806694B2 (en) | 2014-10-14 | 2020-10-20 | The University Of Chicago | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof |
WO2016112268A1 (en) * | 2015-01-08 | 2016-07-14 | Purdue Research Foundation | Radio-luminescent particles for enhancement of radiation cancer therapy |
EA201792560A1 (ru) | 2015-05-28 | 2018-06-29 | Нанобиотикс | Наночастицы для применения в качестве терапевтической вакцины |
US9770688B2 (en) | 2015-10-22 | 2017-09-26 | King Fahd University Of Petroleum And Minerals | Si—Y nanocomposite membrane and methods of making and use thereof |
JP7090034B2 (ja) | 2016-05-20 | 2022-06-23 | ザ ユニバーシティ オブ シカゴ | 化学療法、標的療法、光線力学療法、免疫療法及びそれらの任意の組み合わせのためのナノ粒子 |
US11590225B2 (en) | 2016-12-08 | 2023-02-28 | The Brigham And Women's Hospital, Inc. | Bismuth-gadolinium nanoparticles |
US10283476B2 (en) | 2017-03-15 | 2019-05-07 | Immunolight, Llc. | Adhesive bonding composition and electronic components prepared from the same |
WO2019028250A1 (en) | 2017-08-02 | 2019-02-07 | The University Of Chicago | NOMOGENEOUS ORGANOMETALLIC ORGANOMETRIC ORGANOMETRIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF |
US11191836B2 (en) | 2018-06-01 | 2021-12-07 | Tae Life Sciences, Llc | Biodegradable nanocarrier(s) (BPMOs) for neutron capture therapy and methods thereof |
WO2022117529A1 (en) * | 2020-12-01 | 2022-06-09 | Nanobiotix | Porous, high-z and carbon-free particles as radioenhancers |
CN112655715A (zh) * | 2020-12-25 | 2021-04-16 | 杭州甜蜜按钮科技有限公司 | 一种哺乳期羊舍专用消毒剂的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985173A (en) * | 1997-11-18 | 1999-11-16 | Gray; Henry F. | Phosphors having a semiconductor host surrounded by a shell |
JP3490015B2 (ja) * | 1999-03-11 | 2004-01-26 | 関西ティー・エル・オー株式会社 | 化学的耐久性に優れた放射性微小球及びその製造方法 |
AU2001236798B2 (en) * | 2000-02-08 | 2004-11-04 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
ES2258527T3 (es) * | 2000-05-05 | 2006-09-01 | Bayer Technology Services Gmbh | Nanoparticulas impurificadas como biomarcadores. |
US20020127224A1 (en) * | 2001-03-02 | 2002-09-12 | James Chen | Use of photoluminescent nanoparticles for photodynamic therapy |
JP2007514736A (ja) * | 2003-12-17 | 2007-06-07 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 紫外線放射ナノ粒子を用いた放射線治療および医学画像 |
WO2005107818A2 (en) * | 2004-04-30 | 2005-11-17 | University Of Florida | Nanoparticles and their use for multifunctional bioimaging |
FR2869803B1 (fr) | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | Particules activables, preparation et utilisations |
US20070218049A1 (en) * | 2006-02-02 | 2007-09-20 | Wei Chen | Nanoparticle based photodynamic therapy and methods of making and using same |
-
2004
- 2004-05-10 FR FR0405036A patent/FR2869803B1/fr not_active Expired - Fee Related
-
2005
- 2005-05-09 DE DE602005008731T patent/DE602005008731D1/de active Active
- 2005-05-09 AU AU2005251499A patent/AU2005251499B2/en not_active Ceased
- 2005-05-09 MX MXPA06013095A patent/MXPA06013095A/es active IP Right Grant
- 2005-05-09 PL PL05769516T patent/PL1744789T3/pl unknown
- 2005-05-09 EA EA200602077A patent/EA010246B1/ru not_active IP Right Cessation
- 2005-05-09 WO PCT/FR2005/001145 patent/WO2005120590A1/fr active Application Filing
- 2005-05-09 US US11/579,867 patent/US9162079B2/en active Active
- 2005-05-09 KR KR1020067023550A patent/KR101234334B1/ko active IP Right Grant
- 2005-05-09 JP JP2007512273A patent/JP5150251B2/ja not_active Expired - Fee Related
- 2005-05-09 AT AT05769516T patent/ATE403444T1/de active
- 2005-05-09 BR BRPI0510290A patent/BRPI0510290B8/pt not_active IP Right Cessation
- 2005-05-09 KR KR1020127027128A patent/KR20120123731A/ko not_active Application Discontinuation
- 2005-05-09 PT PT05769516T patent/PT1744789E/pt unknown
- 2005-05-09 DK DK05769516T patent/DK1744789T3/da active
- 2005-05-09 SI SI200530367T patent/SI1744789T1/sl unknown
- 2005-05-09 CN CN200580014476A patent/CN100592921C/zh not_active Expired - Fee Related
- 2005-05-09 EP EP05769516A patent/EP1744789B1/fr active Active
- 2005-05-09 CA CA2564197A patent/CA2564197C/fr active Active
- 2005-05-09 RS RSP-2008/0456A patent/RS50615B/sr unknown
- 2005-05-09 ES ES05769516T patent/ES2312004T3/es active Active
-
2006
- 2006-10-26 IL IL178877A patent/IL178877A/en unknown
- 2006-12-08 ZA ZA200610255A patent/ZA200610255B/xx unknown
-
2007
- 2007-02-28 HK HK07102261.1A patent/HK1099508A1/xx not_active IP Right Cessation
-
2008
- 2008-09-24 CY CY20081101047T patent/CY1108369T1/el unknown
- 2008-10-22 HR HR20080534T patent/HRP20080534T3/xx unknown
-
2015
- 2015-05-08 US US14/707,529 patent/US9433800B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200610255B (en) | Activable particles, preparations and uses | |
IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
BRPI0410185A (pt) | composição para manter a viabilidade de um orgão e célula | |
MX2007010359A (es) | Trans carotenoides, su sintesis, formulacion y usos. | |
WO2006020773A3 (en) | Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use | |
WO2006012527A8 (en) | Bivalent linkers and conjugates thereof | |
EP2003196A3 (en) | Compositions and methods for treating and diagnosing cancer | |
GB2392674A (en) | Mesenchymal cells and osteoblasts from human embryonic stem cell | |
SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004011611A3 (en) | Taci antibodies and uses thereof | |
MX347606B (es) | Nanoparticulas metalicas, preparacion y uso de las mismas. | |
NO20090348L (no) | Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme | |
WO2010057112A3 (en) | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets | |
EA019476B9 (ru) | АНТИТЕЛА ПРОТИВ IL-23p19 И ИХ ПРИМЕНЕНИЕ | |
WO2005067388A3 (en) | Perturbed membrane-binding compounds and methods of using the same | |
MY162640A (en) | Thioninium compounds and their use | |
DE602005026407D1 (de) | Materialien und verfahren zur stimulierung des immunsystems | |
WO2006060171A3 (en) | Methods and compositions related to phage-nanoparticle assemblies | |
ATE411981T1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
SE0300795D0 (sv) | Composition comprising iscom particles and live micro-organisms | |
WO2004104591A3 (en) | Improvements to gamma delta t cell-mediated therapy | |
WO2004094610A3 (en) | Wnt as a factor for cardiac myogenesis | |
ATE375144T1 (de) | Echogene polymermikrokapseln und nanokapseln und verfahren zu ihrer herstellung und verwendung | |
DE502006008777D1 (de) | Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien | |
JO3046B1 (ar) | اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها. |